The earnings call reflects a company in transition, showing signs of recovery with revenue rebounding from Q4 and strong momentum in its data platform and radiopharmaceutical services. However, challenges remain, as evidenced by flat year-over-year revenue, an operating loss, and decreased gross margins. The financial position is stable with a strong cash reserve and no debt. While there are positive developments, the balance between highlights and lowlights suggests cautious optimism.

Company Guidance

During the Champions Oncology First Quarter Fiscal Year 2026 earnings call, CEO Rob Brainin and CFO David Miller provided insights into the company's performance and strategy. The company reported $14 million in revenue for the quarter, marking a rebound from the $12.4 million in Q4 and stabilization compared to the first quarter of the previous year. The company's TOS business led growth, with contributions from the emerging data platform. However, the gross margin declined to 43% from 50% in the previous year due to increased outsourced lab service costs. Despite a GAAP operating loss of $0.5 million, adjusted EBITDA was slightly positive at $60,000. Champions Oncology ended the quarter with $10.3 million in cash and no debt, maintaining financial flexibility. The company is optimistic about the potential of its data and Corellia businesses, with expectations for sequential revenue growth, margin expansion, and cash growth in the latter half of fiscal 2026.

Revenue Rebound

The company delivered $14 million in revenue for Q1, rebounding from $12.4 million in Q4, showing a return to growth and stability.

Strong Data Platform Momentum

The data platform has generated sales for three consecutive quarters, creating the most comprehensive and clinically relevant tumor data set in the industry.

Radiopharmaceutical Services Expansion

The company expanded its radiopharmaceutical services platform, which is expected to reduce costs and improve gross margins by bringing work in-house.

Cash Position and Debt-Free Status

Champions Oncology ended Q1 with $10.3 million in cash and remains debt-free, providing financial flexibility and resilience.

Champions Oncology (CSBR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CSBR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Dec 16, 2025	2026 (Q2)	0.00 / -	0.05	―	―	―
Sep 15, 2025	2026 (Q1)	-0.01 / 0.02	0.11	-81.82% (-0.09)	―
Jul 23, 2025	2025 (Q4)	-0.20 / -0.07	0.01	-800.00% (-0.08)	―
Mar 11, 2025	2025 (Q3)	-0.01 / 0.36	-0.16	325.00% (+0.52)	―
Dec 11, 2024	2025 (Q2)	0.01 / 0.05	-0.15	133.33% (+0.20)	―
Sep 11, 2024	2025 (Q1)	-0.03 / 0.11	-0.16	168.75% (+0.27)	―
Jul 18, 2024	2024 (Q4)	-0.16 / 0.01	-0.17	105.88% (+0.18)	―
Mar 12, 2024	2024 (Q3)	-0.06 / -0.16	-0.16	0.00% (0.00)	―
Dec 12, 2023	2024 (Q2)	-0.16 / -0.15	0.01	-1600.00% (-0.16)	―
Sep 13, 2023	2024 (Q1)	-0.10 / -0.16	0	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CSBR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Sep 15, 2025	$6.83	$8.30	+21.52%
Jul 23, 2025	$7.75	$6.65	-14.19%
Mar 11, 2025	$8.90	$9.79	+10.00%
Dec 11, 2024	$5.84	$5.16	-11.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Champions Oncology Inc (CSBR) report earnings?

Champions Oncology Inc (CSBR) is schdueled to report earning on Dec 16, 2025, After Close (Confirmed).

What is Champions Oncology Inc (CSBR) earnings time?

Champions Oncology Inc (CSBR) earnings time is at Dec 16, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CSBR EPS forecast?

CSBR EPS forecast for the fiscal quarter 2026 (Q2) is 0.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing